Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD
Masafumi Ikeda, Tatsuya Yamashita, Sadahisa Ogasawara, Masatoshi Kudo, Yoshitaka Inaba, Manabu Morimoto, Kaoru Tsuchiya, Satoshi Shimizu, Yasushi Kojima, Atsushi Hiraoka, Kazuhiro Nouso, Hiroshi Aikata, Kazushi Numata, Tosiya Sato, Takuji Okusaka, Junji Furuse (2023). Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD. , 13(2), DOI: https://doi.org/10.1159/000531820.
Article24 days agoAtezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Shukui Qin, Minshan Chen, Ann‐Lii Cheng, Ahmed O. Kaseb, Masatoshi Kudo, Han Chu Lee, Adam C. Yopp, Jian Zhou, Lu Wang, Xiaoyu Wen, Jeong Heo, Won Young Tak, Shinichiro Nakamura, Kazushi Numata, Thomas Uguen, David Hsiehchen, Edward Cha, Stephen P. Hack, Qinshu Lian, Ning Ma, Jessica Spahn, Yulei Wang, Lyndia C. Wu, Pierce K. H. Chow, Alexander Thompson, Mark Danta, Pirooz Poursoltan, Andrew Ddembe Kiberu, Renuka Chittajallu, Siddarth Sood, Rudolf Stauber, Matthias Pinter, Markus Peck‐Radosavljevic, Jochen Decaestecker, Pieter‐Jan Cuyle, Gontran Verset, Hans Van Vlierberghe, Sérgio de Azevedo, Livia Andrade, Ademar Cunha Júnior, Luiza Dib Batista Bugiato Faria, Cheng Tzu Yen, Leandro M. Colli, Jamil Asselah, Petr Kavan, Vladimir Marquez, Mayur Brahmania, Qiang Li, Bao-Cai Xing, Yabing Guo, Zhendong Chen, Haitao Zhao, Tao Peng, Liming Wang, Lu Wang, Hongming Liu, Feixiang Wu, Lun–Xiu Qin, Qichang Zheng, Jieer Ying, Haitao Li, Tianfu Wen, Shukui Qin, Xiaoyu Wen, Yunpeng Liu, Minshan Chen, Boqing Wang, Yuxian Bai, Yifu He, Hong Zhao, Dong Zhou, Chaoliu Dai, Gao‐Jun Teng, Shuzhong Cui, Yi Gao, Xizhi Zhang, Zheng Lu, Tao Yin, Youming Ding, Weidong Jia, Yongxiang Xia, Beicheng Sun, Qiang Xia, Yufeng Yuan, Hui‐Chuan Sun, Xuetao Shi, A. Guzmán, Luis Corrales, Zdeněk Král, Peter Priester, Eugen Kubala, Jean Frédéric Blanc, Marc Bourlière, Jean Marie Péron, Christophe Borg, Jean‐Pierre Bronowicki, Nathalie Ganne–Carrié, Thomas Decaens, Thomas Uguen, Alexandra Heurgué (2023). Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial. , 402(10415), DOI: https://doi.org/10.1016/s0140-6736(23)01796-8.
Article24 days agoIMbrave050: Phase-3-Studie zur adjuvanten Behandlung mit Atezolizumab+Bevacizumab im Vergleich zur aktiven Überwachung bei Patienten mit hepatozellulärem Karzinom, bei denen nach einer Resektion oder Ablation ein hohes Risiko für ein Wiederauftreten der Krankheit besteht
Jörg Trojan, Pierce K. H. Chow, M. Chen, Ann‐Lii Cheng, Ahmed O. Kaseb, Masatoshi Kudo, H. C. Lee, Adam C. Yopp, Jian Zhou, Lei Wang, Xiaoyu Wen, Jun Heo, Won Young Tak, Shinichiro Nakamura, Kazushi Numata, Thomas Uguen, David Hsieh, Edward Cha, Stephen P. Hack, Qinshu Lian, J. Spahn, Chin‐Lee Wu, Shukui Qin (2023). IMbrave050: Phase-3-Studie zur adjuvanten Behandlung mit Atezolizumab+Bevacizumab im Vergleich zur aktiven Überwachung bei Patienten mit hepatozellulärem Karzinom, bei denen nach einer Resektion oder Ablation ein hohes Risiko für ein Wiederauftreten der Krankheit besteht. , 61(08), DOI: https://doi.org/10.1055/s-0043-1771886.
Article24 days agoSupplementary Material for: Multicenter Phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD
Masafumi Ikeda, Tatsuya Yamashita, Sadahisa Ogasawara, Masatoshi Kudo, Yoshitaka Inaba, Manabu Morimoto, Kaoru Tsuchiya, Shinichi Shimizu, Yasushi Kojima, Atsushi Hiraoka, Kazuhiro Nouso, Hiroshi Aikata, Kazushi Numata, Tosiya Sato, Takuji Okusaka, Junji FuruseSupplementary Material for: Multicenter Phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD. , DOI: https://doi.org/10.6084/m9.figshare.23640789.
Dataset24 days agoReal-world dosing of regorafenib in patients with unresectable hepatocellular carcinoma (uHCC): Final analysis of the prospective, observational REFINE study.
Richard S. Finn, Philippe Merle, Masafumi Ikeda, Heinz‐Josef Klümpen, Gianluca Masi, Alessandro Granito, Ho Yeong Lim, Masatoshi Kudo, Shukui Qin, René Gerolami, Yi‐Hsiang Huang, Do Young Kim, Matthias Pinter, Naoya Kato, Masayuki Kurosaki, Kazushi Numata, Javeed Khan, Kirhan Özgürdal, Yoon Jun Kim (2023). Real-world dosing of regorafenib in patients with unresectable hepatocellular carcinoma (uHCC): Final analysis of the prospective, observational REFINE study.. , 41(4_suppl), DOI: https://doi.org/10.1200/jco.2023.41.4_suppl.518.
Article24 days ago